Yegor Voronin

Experience

• 

  National Cancer Institute

  Feb 1999 - Sept 2003

  Predoctoral Fellow
• 

  Fred Hutchinson Cancer Research Center

  Sept 2003 - Dec 2008

  Postdoctoral fellow
• 

  Emerald Ballet Theatre

  Feb 2006 - Dec 2008

  Vice-President of Board of Directors
• 

  Global HIV Vaccine Enterprise

  Jan 2009 - Jan 2018

  Liaised with key opinion leaders to identify field-wide R&D challenges in the HIV vaccine field and developed alliances to design and implement potential solutions. Translated organizational vision into specific programs and initiatives; developed work plans and budgets, tracking milestones; wrote, edited and published white papers, peer-reviewed articles, and reports; promoted organizational priorities via presentations at conferences, webinars, email campaigns, and site visits to stakeholder organizations; set agenda and led internal meetings of cross-functional teams; presented organizational priorities to the Board of Directors. - Launched and managed the Timely Topics in HIV Vaccines initiative, comprising 20+ projects, bringing together major stakeholders and key opinion leaders to develop solutions to field-wide R&D challenges.- Managed the HIV Envelope Protein Manufacturing alliance, bringing together 21 members representing 13 organizations to collectively solve technical challenges in production, purification and characterization of recombinant HIV Envelope immunogens for early-stage clinical trials.- Conceptualized, developed, and delivered trainings, workshops, wesbites and printed materials to educate academic researchers on tools and approaches used in industry to advance vaccine candidates. Show less

  • Senior Science Officer

    May 2013 - Jan 2018

  • Science Officer

    Jan 2009 - May 2013
• 

  Visual Science

  Jan 2010 - Jan 2010

  Scientific Consultant

  Researched, organized, and summarized information on the structural characteristics of an HIV virion to support development of a 3-D model of HIV that won the first place for Illustration in “Visualization Challenge” competition organized by the National Science Foundation and the Science magazine.

• 

  International AIDS Vaccine Initiative (IAVI)

  Jan 2014 - Jan 2017

  Science Writer (Consultant)

  Authored invited articles for IAVI Report, a quarterly publication on the state of HIV vaccine research and development.

• 

  Worcester HIV Vaccine

  May 2018 - May 2021

  Chief Operating Officer

  Development of a globally-relevant preventive HIV vaccine based on the DNA-prime/protein-boost approach with polyvalent immunogens. - Completed GMP manufacturing of a 5-valent DNA vaccine for the Phase IIa clinical trial- Established and implemented QA systems for oversight of GMP manufacturing- Designed and oversaw GMP stability studies- Developed company's operations and manage day-to-day activities- Advancing clinical testing of the vaccine to the Phase IIa clinical trial- Coordinating interactions with regulatory agencies- Overseeing GLP assay development- Establishing contracts and agreements with external partners- Building and maintaining relationships with partners and collaborators Show less

• 

  Bristol Myers Squibb

  May 2021 - now

  Director, Academic Research Collaborations Lead